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The Hippo (Hpo) signaling pathway controls tissue
growth and organ size in species ranging from
Drosophila to mammals and is deregulated in a
wide range of human cancers. The core pathway
consists of the Hpo/Warts (Wts) kinase cassette
that phosphorylates and inactivates the transcrip-
tional coactivator Yorkie (Yki). Here, we report that
Echinoid (Ed), an immunoglobulin domain-contain-
ing cell adhesion molecule, acts as an upstream
regulator of the Hpo pathway. Loss of Ed compro-
mises Yki phosphorylation, resulting in elevated Yki
activity that increases Hpo target gene expression
and drives tissue overgrowth. Ed physically interacts
with and stabilizes the Hpo-binding partner Salvador
(Sav) at adherens junctions. Ed/Sav interaction is
promoted by cell-cell contact and requires dimeriza-
tion of Ed cytoplasmic domain. Overexpression of
Sav or dimerized Ed cytoplasmic domain sup-
pressed loss-of-Ed phenotypes. We propose that
Edmay link cell-cell contact to Hpo signaling through
binding and stabilizing Sav, thus modulating the Hpo
kinase activity.
INTRODUCTION
Howmulticellular organisms control their growth to reach proper
organ size during development is a fascinating question. Recent
studies, initially of Drosophila, have identified an evolutionarily
conserved pathway, the so-called Hippo (Hpo) tumor sup-
pressor pathway, as a crucial mechanism that controls tissue
growth and organ size by simultaneously inhibiting cell growth
and proliferation and promoting cell death (Halder and Johnson,
2011; Pan, 2010; Zhang et al., 2009a). The Hpo signaling
pathway has also been implicated in cell contact-dependent
growth inhibition (Zhao et al., 2007), and deregulation of the
Hpo pathway has been linked to a wide range of human cancers
(Pan, 2010).
Central to the Hpo pathway is a kinase cassette consisting
of four tumor suppressor proteins, the Ste20-like kinase HpoDevelopm(Harvey et al., 2003; Jia et al., 2003; Pantalacci et al., 2003;
Udan et al., 2003; Wu et al., 2003), the WW domain-containing
protein Salvador (Sav) (Kango-Singh et al., 2002; Tapon et al.,
2002), the NDR family kinase Warts (Wts) (Justice et al., 1995;
Xu et al., 1995) and the Mob family protein Mats (Lai et al.,
2005). The kinase activities of Hpo and Wts are facilitated by
their regulatory proteins Sav and Mats, respectively. Activated
Hpo/Sav complex phosphorylates and activates the Wts/Mats
complex (Jia et al., 2003; Wei et al., 2007), which in turn phos-
phorylates and inactivates the transcriptional coactivator Yorkie
(Yki) (Huang et al., 2005). Phosphorylation of Yki restricts its
nuclear localization through recruiting 14-3-3 (Dong et al., 2007;
Oh and Irvine, 2008; Ren et al., 2010; Zhang et al., 2008). When
the activity of the Hpo/Wts kinase cassette is compromised,
Yki forms complexes with transcription factors, including
Scalloped (Sd), and translocates to the nucleus to activate Hpo
pathway target genes, including cyclin E, diap1, and the micro-
RNA bantam that regulate cell growth, proliferation, and survival
(Goulev et al., 2008; Wu et al., 2008; Zhang et al., 2008).
The Hpo/Wts kinase cassette is regulated at several levels by
multiple upstream modulators, including the atypical cadherins
Dachsous (Ds) and Fat (Ft) (Bennett and Harvey, 2006; Cho
et al., 2006; Matakatsu and Blair, 2006; Silva et al., 2006;
Willecke et al., 2006), the FERM-domain proteins Expanded
(Ex) and Merlin (Mer) (Cho et al., 2006; Hamaratoglu et al.,
2006; Maitra et al., 2006; Pellock et al., 2007), the WW- and C2
domain-containing protein Kibra (Baumgartner et al., 2010;
Genevet et al., 2010; Yu et al., 2010), and cell polarity determi-
nants such as Crumbs (Crb) and lethal (2) giant larvae (Lgl)
(Chen et al., 2010; Grzeschik et al., 2010; Ling et al., 2010;
Robinson et al., 2010). Ds functions as a ligand for Ft, and
binding of Ds to Ft stabilizes Wts by inhibiting Dachs-mediated
degradation of Wts (Cho et al., 2006). The apical membrane-
localized Ex/Mer/Kibra complex interacts with Hpo/Sav and
facilitates Hpo activation likely by retaining Hpo at the apical
surface (Baumgartner et al., 2010; Genevet et al., 2010; Yu
et al., 2010). Reduced protein levels or mislocalization of Ex at
the apical surface have been observed in imaginal disc cells
overexpressing the Crb intracellular domain or lacking Crb func-
tion, whichmay contribute to the deregulation of Hpo signaling in
these cells (Chen et al., 2010; Grzeschik et al., 2010; Ling et al.,
2010; Robinson et al., 2010).
The relative contribution of the upstream Hpo pathway regula-
tors varies depending on tissue types. For example, loss of Ft inental Cell 22, 255–267, February 14, 2012 ª2012 Elsevier Inc. 255
Figure 1. Inactivation of Ed Induces Tissue Overgrowth and
Enhances Yki Gain-of-Function Phenotype
(A–D0) Side (A–D) and dorsal (A0–D0) views of a control adult fly eye (A and A0) or
eyes expressing UAS-Yki (B and B0) or UAS-Yki + UAS-Ed-RNAi3087 (C and C0)
with GMR-Gal4, or expressing UAS-Ed-RNAi3087 with ey-Gal4 (D and D0).
(E–F0 ) Side (E and F) and dorsal (E0 and F0) views of mosaic eyes containing
control clones (E and E0) or ed clones (F and F0) induced by ey-FLP.
(G–J) A control adult fly wing (G) and wings expressing UAS-Ed-RNAi937 (H),
UAS-Sav-RNAi (I), orUAS-Ed-RNAi937 +UAS-Ed (J) with hh-Gal4 at 29C. Red
dashed lines indicate the A/P compartment boundary.
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sive genes and marked tissue overgrowth but did not perturb
Hpo signaling in Drosophila ovarian follicle cells (Meignin et al.,
2007; Polesello and Tapon, 2007). To the contrary, Kibra is a crit-
ical regulator of Hpo signaling in Drosophila ovarian follicle cells,256 Developmental Cell 22, 255–267, February 14, 2012 ª2012 Elsevbut its loss of function mutation only weakly activated Hpo
pathway genes and causedminor overgrowth of imaginal tissues
(Genevet et al., 2010; Yu et al., 2010). Thus, the wiring of the Hpo
signaling network may depend on the developmental context.
To identify additional Hpo pathway regulators, we carried out
a genetic modifier screen and identified Echinoid (Ed), an immu-
noglobulin domain-containing cell adhesion molecule (Bai et al.,
2001; Wei et al., 2005), as an upstream regulator of the Hpo
pathway. We found that loss of Ed in imaginal discs attenuates
Yki phosphorylation at S168 and promotes Yki nuclear localiza-
tion, resulting in elevated Yki activity that drives tissue over-
growth. We also found that Ed is required for proper Hpo
signaling in ovarian follicle cells. We demonstrated that Ed forms
a complex with Sav to regulate its stability in S2 cells and that Ed
is required for the enrichment of Sav at adherens junctions
in vivo. In addition, we found that Ed/Sav interaction is promoted
by cell-cell contact and requires dimerization/oligomerization of
Ed cytoplasmic domain.
RESULTS
Loss of Ed Promotes Tissue Overgrowth
To identify new components of the Hpo signaling pathway, we
carried out a genetic modifier screen in which flies carrying
GMR-Gal4 andUAS-Yki (referred to asGMR > Yki) were crossed
to a collection of transgenic RNAi lines from the Vienna
Drosophila RNAi Center (VDRC) and the Bloomington Stock
Center, and we looked for enhancers or suppressors of the
overgrown eye phenotype caused by Yki overexpression. From
this screen, we found that an RNAi line that targets Ed (UAS-
Ed-RNAi3087; Figure S1A) enhanced GMR > Yki mediated over-
growth, although expression of UAS-Ed-RNAi3087 using GMR-
Gal4 in otherwise wild-type eyes did not cause any discernible
overgrowth (Figures 1A–1C0; data not shown). However, expres-
sion ofUAS-Ed-RNAi3087 using the eyeless-Gal4 (ey-Gal4) driver,
which drives the expression of UAS transgene in eye discs start-
ing at a much earlier stage than GMR-Gal4 (Halder et al., 1998),
resulted in eye overgrowth (Figures 1D and 1D0).
To further probe the role of Ed in growth control, we expressed
several UAS-Ed-RNAi lines from the VDRC in the posterior
compartment of wing imaginal discs using hh-Gal4 (referred to
as hh > Ed-RNAi). As shown in Figure 1H and Figure S1 (available
online), inactivation of Ed by hh > Ed-RNAi produced adult wings
with enlarged posterior compartments. RNAi-mediated knock-
down of ed expression was confirmed by immunostaining with
an Ed antibody (Figures 2A and 2A0). The overgrowth phenotype
induced by hh > Ed-RNAi is unlikely due to an off-target effect
because expression of three different transgenic RNAi lines
(VDRC #937, #3087, and #104279) targeting two nonoverlapping
regions of the ed coding sequence produced a similar over-
growth phenotype in adult wings (Figures S1A, S1C–S1E). We
also generated a UAS-Ed-RNAi line that targets a C-terminal
region of Ed (UAS-Ed-RNAiC ; Figure S1A) and found that
expression of this line by hh-Gal4 also produced an enlarged
posterior compartment (Figure S1F). Furthermore, overexpres-
sion of a UAS-Ed transgene suppressed wing overgrowth
caused by hh > Ed-RNAi (Figure 1J).
We then determined whether ed mutation could render
tissue overgrowth.We generatedmosaic eyes that contain eitherier Inc.
Figure 2. Inactivation of Ed Increases the Expres-
sion of Multiple Hpo Pathway Target Genes
(A and A0 ) A wing disc expressing UAS-GFP + UAS-Ed-
RNAi104279with hh-Gal4 and immunostained with anti-GFP
(A) and anti-Ed (A0) antibodies. GFP marked the posterior
compartment (arrows) where hh-Gal4 is expressed.
(B–E0) Wild-type wing discs (B, C, D, and E) or wing discs
expressing UAS-Ed-RNAi104279 (B0, C0, D0, and E0) or UAS-
Ed-RNAi104279 + UAS-Ed (C00) with hh-Gal4 and immuno-
stained to show the expression of diap1-GFP (B and B0),
ex-lacZ (C–C00), Wg (green in D and D0), Ci (red in D and D0),
and bantam sensor (BS; E and E0). Arrows in (B–C00), (E),
and (E0) indicate posterior compartments. Arrows and
asterisks in (D and D0) indicate Wg expression at the
periphery of the wing pouch region and along the D/V
compartment boundary, respectively. Ci expression (red in
D and D0) marks the A compartment.
(F and F0) A large magnification view of an eye disc con-
taining ed mutant clones and immunostained to show the
expression of LacZ (green; F0) and DIAP1 (red; F and F0 ). ed
mutant clones are marked by the lack of LacZ expression
and exhibit elevated DIAP1 expression (arrows; F and F0 ).
(G and G0) A wing disc carrying ed mutant clones was
immunostained to show the expression of LacZ (green; G0)
and Wg (red; G and G0). ed mutant cells are marked by
the lack of LacZ expression. ed mutant cells exhibit
elevatedWg expression at the periphery of the wing pouch
region (arrows) but normal Wg expression along the D/V
boundary (asterisks).
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system (Newsome et al., 2000). As shown in Figures 1E–1F0,
mosaic eyes containing ed mutant clones were overgrown
compared with the control mosaic eyes. The overgrowth pheno-
type caused by ed mutation is less severe compared with those
caused by hpomutations (Jia et al., 2003) but is comparable with
those caused by kibra mutations (Baumgartner et al., 2010;
Genevet et al., 2010; Yu et al., 2010).
Loss of Ed Upregulates Hpo Pathway Target Genes
The enlarged wing phenotype induced by hh > Ed-RNAi
resembles those caused by loss of Hpo pathway components
including Sav and Wts in posterior compartments (Figure 1I)
(Genevet et al., 2010). We therefore determined whether loss
of Ed led to deregulation of Hpo pathway target genes. As shown
in Figure 2, expression of UAS-Ed-RNAi by hh-Gal4 led to the
upregulation of diap1-GFP and ex-lacZ that faithfully report
the expression of diap1and ex, respectively (Figures 2B–2C0;
Hamaratoglu et al., 2006; Zhang et al., 2008). Consistent with
this, DIAP1 was upregulated in ed mutant clones induced in
eye discs (Figures 2F and 2F0). In addition, overexpression of
a UAS-Ed transgene suppressed elevated ex-lacZ expression
caused by hh > Ed-RNAi (Figure 2C00). Of note, we cannot
examine ex-lacZ expression in ed mutant clones because
ex-lacZ and ed are located on the same chromosomal arm.
Wg expression at the periphery of wing pouches is under the
control of the Hpo signaling activity (Cho et al., 2006). We found
that wing discs expressing hh > Ed-RNAi exhibited elevated
Wg expression in these regions of the posterior compartmentDevelopm(indicated by the arrows in Figure 2D0), consistent with the notion
that loss of Ed deregulates the Hpo signaling activity. In contrast,
Wg expression along the dorsoventral (D/V) compartment
boundary, which is under the control of Notch (N) signaling
activity, was not affected by Ed RNAi (indicated by the asterisk
in Figure 2D0). Similarly, ed mutant clones exhibited elevated
Wg expression at the periphery of wing pouches (arrows in
Figures 2G and 2G0). In contrast, Wg expression along the D/V
compartment boundary remained unchanged in ed mutant
clones (asterisks in Figures 2G and 2G0).
We also examined the expression of a bantam sensor,
bantam-GFP, which inversely reports the expression level of
the bantam microRNA (Thompson and Cohen, 2006). As shown
in Figure 2E0, wing discs expressing hh > Ed-RNAi exhibited
reduced levels of bantam-GFP expression in posterior compart-
ment cells, suggesting that loss of Ed upregulates bantam.
Taken together, these observations demonstrate that loss of
Ed increases the expression of multiple Hpo pathway target
genes and further suggest that tissue overgrowth caused by
Ed inactivation is due to deregulation of Hpo signaling activity.
Ed Regulates Hpo Signaling in Ovarian Follicle Cells
The Hpo pathway is required for the proper maturation of poste-
rior follicle cells and oocyte polarity formation during oogenesis
(Meignin et al., 2007; Polesello and Tapon, 2007; Yu et al.,
2008). In large posterior follicle cell clones mutant for Hpo
pathway components including hpo, wts, sav, and ex, the N
pathway is deregulated, leading to a failure of posterior follicle
cells to undergo a switch from mitotic cycle to endocycle. Asental Cell 22, 255–267, February 14, 2012 ª2012 Elsevier Inc. 257
Figure 3. Loss of Ed Phenocopies Loss of Hpo Signaling in Ovary
(A–F0) Stage 8 wild-type (A–A00 0, C–C00 0, and E–E0) and mosaic egg chambers carrying ed mutant clones (B–B00 0, D–D00 0, and F–F0) were immunostained with
antibodies against Cut (green in A and B), GFP (green in C and D), and LacZ (red) and the nuclear dye, DRAQ5 (blue). In all panels, the posterior is to the right. The
dashed lines outline the mutant follicle cell clones that are marked by the lack of LacZ expression, and the solid lines indicate the posterior follicle cells. Cut
expression is downregulated in follicle cells at stage 8, and its expression remains in the anteriorly and posteriorly localized polar cells (A). Cut expression is
prolonged in posterior edmutant follicle cell clones (arrow in B). There is a singer layer of follicle cells surrounding the wild-type oocyte (A00 and C00), but multiple
layers of follicle cells are found in posterior edmutant follicle cell clones (B00 and D00). The expression of Hpo pathway target gene diap1-GFP is weak in posterior
follicle cells (C) but is upregulated in posterior edmutant follicle cells (arrow in D). The oocyte nucleus is localized at the anterior-dorsal corner (arrows in E and E0)
but is mislocalized at the posterior pole of the oocyte with large ed follicle cell clones (arrows in F and F0 ).
(G–H0) Stage 9 wild-type (G and G0) and mosaic egg chambers carrying edmutant clones (H and H0) were immunostained with antibodies against Grk (red) and
LacZ (green) and the nuclear dye, DRAQ5 (blue). Grk is localized at the anterior-dorsal corner of wild-type oocytes (arrows in G and G0) but is mislocalized at the
posterior pole of oocytes associated with large posterior ed follicle cell clones marked by the lack of LacZ staining (arrows in H and H0).
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and accumulate in multiple layers. We found that the N pathway
target gene cut was ectopically expressed and that multilayers
formed in posteriorly situated ed mutant follicle cell clones
(Figures 3B–3B00 0). In addition, posterior ed mutant follicle cells
exhibited elevated expression of the Hpo pathway reporter
diap1-GFP (Figures 3D–3D00 0). Posterior follicle cell clones
mutant for hpo pathway components cause oocyte polarity
defects such as mislocalization of oocyte nuclei (Meignin et al.,
2007; Polesello and Tapon, 2007; Yu et al., 2008). We found258 Developmental Cell 22, 255–267, February 14, 2012 ª2012 Elsevthat posterior follicle cell clones mutant for ed also resulted
in mislocalization of oocyte nuclei and Gurken (Grk) protein
(Figures 3F, 3F0, 3H, and 3H0). Thus, loss of Ed phenocopies
loss of Hpo signaling in Drosophila ovaries.
Ed Regulates Yki Phosphorylation and Nuclear
Localization
The expression of Hpo pathway target genes is controlled by
the transcriptional coactivator Yki, whose activity is primarily
regulated by phosphorylation-mediated nuclear exclusion.ier Inc.
Figure 4. Ed Acts Upstream of Sav to Regulate Yki Phosphorylation and Nuclear Localization
(A) Western blot analysis of Yki and phospho-Yki for wild-type wing discs or wing discs expressing UAS-Ed-RNAi104279with theMS1096Gal4 driver. The bottom
panel is western blot for a-tubulin as a loading control.
(B–B00) A wing disc expressing ex-lacZ andUAS-Ed-RNAi104279with hh-Gal4was immunostained with Yki (green; B0 and B00) and LacZ (red; B0 and B00) antibodies.
The A/P boundary is demarcated by white lines based on Ci staining (not shown). Of note, Yki colocalized with LacZ in the nucleus of posterior compartment cells
(arrows).
(C–E) Adult fly wings expressing UAS-Ed-RNAi973 (C), UAS-Ed-RNAi973 + UAS-Yki-RNAi (D), or UAS-Ed-RNAi973 + UAS-Sav (E) with hh-Gal4 at 29C. Red
dashed lines demarcate the A/P compartment boundary.
(F–I) A wild-type wing disc (F) or wing discs expressing UAS-Ed-RNAi104279 (G), UAS-Ds-RNAi (H), or UAS-Ed-RNAi104279 + UAS-Ds-RNAi (I) withMS1096. The
discs also expressed UAS- dicer2 to enhance the RNAi efficiency.
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Yki nuclear localization, thereby limiting Yki activity in the
nucleus (Dong et al., 2007; Oh and Irvine, 2008; Ren et al.,
2010; Zhang et al., 2008). The increased expression of multiple
Hpo pathway genes in hh > Ed-RNAi wing discs suggests that
Yki activity is upregulated by loss of Ed. We therefore examined
the Yki phosphorylation status using a phosphospecific antibody
that recognizes phosphorylated S168 (pS168) (Dong et al.,
2007). We found that expression of UAS-Ed-RNAi using the
wing-specific Gal4 driver MS1096 led to a marked reduction in
the level of S168 phosphorylation (Figure 4A). Consistent with
diminished S168 phosphorylation, loss of Ed led to increased
nuclear localization of Yki in hh > Ed-RNAi wing discs (Figures
4B–B00). These results suggest that Ed inactivation may compro-
mise the Hpo/Wts kinase activity, leading to reduced Yki phos-
phorylation and increased Yki nuclear localization and activity.
If upregulation of Yki activity is responsible for the phenotypes
induced by Ed inactivation, one would expect the reduction
of Yki activity to attenuate the phenotypes caused by loss of
Ed. Indeed, Yki RNAi suppressed the overgrowth phenotype
induced by loss of Ed (Figure 4D). In addition, Yki RNAi sup-Developmpressed the ed mutant phenotypes in Drosophila ovaries
(Figures S2B–S2B00).
Ed Acts in Parallel with Ds/Ft
We next investigated how loss of Ed compromised the activity of
the Hpo/Wts kinase cassette. Ed is a multifunctional protein that
has been implicated in restricting the activity of EGFR (Bai et al.,
2001; Spencer and Cagan, 2003). However, EGFR RNAi did not
block the upregulation of ex-lacZ induced by Ed RNAi, and over-
expression of a constitutively active form of MAP kinase
(MAPKCA) by hh-Gal4 failed to activate ex-lacZ expression in
wing discs (Figures S3A–S3C0). Thus, Ed does not act through
the EGFR pathway to regulate Hpo pathway-responsive genes.
Ft regulates the Hpo/Wts kinase cassette through the noncon-
ventional Myosin Dachs (Cho et al., 2006). Inactivation of Dachs
by RNAi effectively blocked tissue overgrowth and elevated
expression of ex-lacZ and Wg induced by Ft RNAi (Figures
S3D–S3E0). In contrast, Dachs RNAi did not suppress the
elevated expression of ex-lacZ and Wg induced by Ed RNAi
(Figures S3F and S3F0), suggesting that Ed does not act through
the Ft/Dachs branch of the Hpo pathway. Consistent with thisental Cell 22, 255–267, February 14, 2012 ª2012 Elsevier Inc. 259
Figure 5. Ed Interacts with Multiple Hpo Pathway Components
(A) A schematic drawing of full-length Ed (EdFL) and its deletion constructs. Black boxes denote the transmembrane domain of Ed.
(B–H) S2 cells were transfected with DNA constructs expressing epitope-tagged full-length or indicated truncated Ed and tagged Hpo pathway components
including Sav (B–C, H), Hpo (C), Ex (D), Mer (E), Kibra (F), or Yki (G). Cell lysates were immunoprecipitated, followed by western blot analysis with the indicated
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Ed to activate an Hpo pathway reporter, HREx8-GFP, which
contains eight copies of a 32 bp Hpo-responsive element
(Figures 4F–4I; Wu et al., 2008). These observations suggest
that Ed may act in parallel with Ds/Ft to regulate Hpo signaling.
We next examined the epistatic relationship between Ed and
the Hpo kinase cassette. We coexpressed UAS-Sav in hh >
Ed-RNAi wing discs and found that Sav overexpression sup-
pressed the tissue overgrowth induced by loss of Ed (Figure 4E).
We also generated MARCM clones in ovarian follicle cells that
lack Ed and express UAS-Sav under the control of tub-Gal4
and found that overexpression of Sav suppressed the ectopic
cut expression and multilayer associated with posterior ed
mutant follicle cells (Figures S2C–S2C00). These observations
suggest that Ed acts upstream of, or in parallel with, Sav to regu-
late Hpo signaling.
Ed Physically Interacts with Multiple Hpo Pathway
Components and Regulates Hpo Signaling through
Its Intracellular Domain
To understand the molecular mechanism by which Ed regulates
Hpo signaling, we examined physical interactions between Ed
and membrane proximal Hpo pathway components by coimmu-
noprecipitation experiments. S2 cells were transfected with a
C-terminally Myc-tagged full-length Ed (EdFL-Myc) or truncated
Ed that lacks the intracellular domain (EdDC-Myc; Figure 5A)
and HA-tagged Ex, Mer, or Sav, or they were transfected
with HA-tagged EdFL or EdDC (EdFL-HA or EdDC-HA) and Myc-
tagged Kibra. Cell extracts were immunoprecipitated with the
corresponding antibodies, followed by western blot analysis.
As shown in Figure 5, EdFL-Myc, but not EdDC-Myc, was coim-
munoprecipitated with HA-Sav and HA-Ex (Figures 5B and
5D), and to a lesser extent with HA-Mer (Figure 5E). Myc-Kibra
was coimmunoprecipitated with EdFL-HA but not EdDC-HA
(Figure 5F). These observations suggest that Ed interacts
with Sav, Ex, Mer, and Kibra through its intracellular domain.
In addition, we found that EdFL-Myc was barely associated
with Flag-Hpo, but their association was facilitated by coexpres-
sion of HA-Sav (Figure 5C), suggesting that Sav may bring
Hpo to Ed. Interestingly, we found that Ed interacted with Yki
but not with Sd through its intracellular domain (Figure 5G;
Figure S4I).
When expressed in S2 cells alone, HA-Sav and HA-Ex ex-
hibited diffused patterns of cytoplasmic staining (Figures S4A
and S4C). Coexpression of EdFL-Myc resulted in the recruitment
of HA-Sav and HA-Ex to the plasma membrane where they
colocalized with EdFL-Myc (Figures S4B and S4D). These obser-
vations further support the notion that Ed physically interactsantibodies (top panels), or directly subjected to western blot analysis with the ind
Arrows in B indicate the cleaved Ed.
(I) A schematic drawing of full-length Sav and its deletion mutants. TheWWand CC
individual Sav constructs to interact with Ed is indicated by a plus or minus sym
(J) S2 cells were transfected with DNA constructs expressing Myc-tagged EdFL
precipitated with anti-HA antibody, followed by western blot analysis with anti-M
Myc or anti-HA antibody (middle and bottom panels). Asterisks indicate weak ba
(K–N0) Wing discs expressing UAS-Ed-RNAi3087 (K and K0), UAS-Ed-RNAi3087 + U
or UAS-Ed-RNAi3087 + UAS-EdTMCD2-Myc (N and N0) with hh-Gal4 and immun
Ed transgenes with comparable Myc expression levels were used for the rescue
Developmwith Sav and Ex and suggest that Ed can bring Sav and Ex to
the cell membrane. We also confirmed that endogenous
Ed and Sav form a complex in wing-disc-derived cl8 cells
(Figure S4E).
We next generated an Ed variant lacking the N-terminal
extracellular domain, which we named EdTMC (TMC stands for
transmembrane plus cytoplasmic domain; Figure 5A). We found
that C-terminally Myc-tagged EdTMC (EdTMC-Myc) interacted
with HA-tagged Sav, Ex, Mer, and Yki in coimmunoprecipitation
assays (Figure 5H; Figures S4F–S4H). Deleting aa1217-1332
from EdTMC (EdTMCD1-Myc; Figure 5A) greatly reduced the
binding to Sav, Ex, and Mer, whereas deleting aa1115-1332
(EdTMCD2-Myc; Figure 5A) abolished the binding to these
proteins (Figure 5H; Figures S4F and S4G), suggesting that the
C-terminal 218 amino acids of Ed mediate its interaction with
Sav and Ex/Mer. In contrast, both EdTMCD1 and EdTMCD2 inter-
acted with Yki in a manner similar to that of EdTMC (Figure S4H),
suggesting that the membrane-proximal region of Ed C-tail
mediates Yki binding.
To map the domains in Sav that mediate interaction with Ed,
we coexpressed full-length Ed with a number of truncated forms
of Sav (Figure 5I). We found that the N-terminal region and WW
domain of Sav are both required for its optimal binding to Ed,
as deleting either domain from Sav (SavC1 or SavDC3) greatly
reduced its binding to Ed and combined deletion (SavC2)
completely abolished the interaction (Figure 5J). In contrast,
deleting the region C-terminal to the WW domain (SavDC1 and
SavDC2) did not affect Sav/Ed interaction (Figure 5J).
Deleting the intracellular domain of Ed (EdDC) blocked its ability
to rescue the loss-of-Ed phenotypes both in wing discs and in
posterior follicle cells (Figures S2E–S2E00 and Figures S7C and
S7C0). On the other hand, overexpression of EdTMC suppressed
the loss-of-Ed phenotypes (Figures 5L and L0; Figures S2F–
S2F00). These observations suggest that Ed regulates Hpo
signaling through its intracellular domain, likely by interacting
with multiple intracellular Hpo pathway components. Consistent
with this notion, deleting the domain involved in binding to Sav/
Hpo and Ex/Mer from EdTMC (EdTMCD1 and EdTMCD2) abolished
its ability to suppress the elevated expression of ex-lacZ induced
by loss of Ed in wing discs (Figures 5M–5N0).
Ed Regulates Sav Stability and Subcellular Localization
In the course of characterizing Ed/Sav interaction, we found that
coexpression of EdFL-Myc stabilized transfected HA-Sav (Fig-
ure 6A). Stabilization of Sav is mediated by the intracellular
domain of Ed as EdDC failed to stabilize Sav, whereas EdTMC
stabilized Sav albeit less effectively than EdFL (Figure 6A). We
alsomeasured the half-life of HA-Sav in the absence or presenceicated antibodies (bottom panels). Asterisks in H and J indicate weak bands.
domains are indicated by shaded and black boxes, respectively. The ability of
bol.
and indicated HA-tagged Sav deletion constructs. Cell lysates were immuno-
yc antibody (top panel), or directly subjected to western blot analysis with anti-
nds.
AS-EdTMC-Myc (L and L0), UAS-Ed-RNAi3087 + UAS -EdTMCD1-Myc (M and M0),
ostained to show the expression of Ci (red), ex-lacZ (green) and Myc (blue).
experiments.
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Figure 6. Ed Regulates the Stability and Apical Localization of Sav
(A) Western blot analysis of cell lysates from S2 cells transfected with the indicated constructs. Myc-CFP (arrow) was cotransfected as an internal control.
Samples were boiled and loaded immediately after 23 SDS loading buffer was added into cell lysates.
(B) S2 cells were transfected with HA-Sav in the absence or presence of EdFL-Myc and treated with cycloheximide for the indicated time. Cell lysates were
subjected to western blot analysis using anti-Myc antibody. Myc-CFP (arrow) was cotransfected as an internal control.
(C) Quantification of HA-Sav in the absence or presence of EdFL-Myc by western blot analysis performed in B.
(D) Western blot analysis of cell lysates from S2 cells transfected with HA-Sav and Myc-CFP and treated with MG132 for 4 hr before harvesting. Myc-CFP (lower
panel) served as a transfection and loading control.
(E–F0 ) Wing discs expressing UAS-Sav-RNAi with hh-Gal4 were immunostained with an anti-Sav antibody (green) and the nuclear dye, DRAQ5 (red in E0), or an
anti-Ed antibody (red in F0). Sav exhibited cytoplasmic staining, which was abolished by Sav-RNAi.
(G–G00) Transverse section view of wild-type wing discs immunostained with Ed (red) and Sav antibodies (green). Sav was enriched at the apical plasma
membrane where it colocalized with Ed at adherens junctions.
(H–I00 0) Transverse section view of a wing disc expressing UAS-Ed-RNAi104279 with hh-Gal4 and immunostained to show the expression of Sav (green in H0 and
H00), Ed (red in H and H00) or E-cadherin (E-cad; red in I0 and I00 0) and En (blue in I00 and I00 0) that marks the P compartment. Loss of Ed resulted in reduced Sav
accumulation at the apical surface.
(J–K00 0) Wild-type (J–J00 0 ) andmosaic egg chambers carrying edmutant clones (K–K00 0 ) were immunostained to show the expression of Sav (green), LacZ (red), and
phalloidin (blue). edmutant follicle cells are marked by the lack of LacZ expression (arrows in K–K0). Posterior edmutant follicle cells showed reduced Sav signals
at the apical surface marked by phalloidin.
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without EdFL-Myc. The levels of HA-Sav were monitored at
different time points after treatment with the protein synthesis
inhibitor, cycloheximide (CHX). As shown in Figure 6, the half-262 Developmental Cell 22, 255–267, February 14, 2012 ª2012 Elsevlife of HA-Sav was less than 2 hr in the absence of EdFL-Myc;
however, coexpression of EdFL-Myc increased the half-life of
HA-Sav to 8 hr (Figures 6B and 6C). We also found that treating
transfected cells with the proteasome inhibitor MG132 increasedier Inc.
Figure 7. Regulation of Ed/Sav Interaction by Dimerization and Cell-Cell Contact
(A) Schematic drawings of full-length Ed and Ed variants. Black bars indicate the Ed transmembrane domain. Triangle and gray box represent a myristoylation
(Myr) signal and a CC dimerization domain, respectively.
(B and C) S2 cells were transfected with the indicated constructs. Cell lysates were immunoprecipitated with anti-HA or anti-Myc antibody, followed by western
blot analysis with the indicated antibodies (top two panels) or directly subjected to western blot analysis with anti-Myc or anti-HA antibody (bottom two panels).
Asterisks in (B) indicate weak bands. Arrows indicate IgG.
(D) FRET efficiency of indicated pairs of CFP/YFP constructs transfected into S2 cells (mean ± SD, nR 10).
(E–G00) S2 cells were transfected with tub-Sav-GFP (green) and tub-EdFL-Myc or tub-EdTMCD1-Myc (red). Immunostaining was carried out after cell aggregation
was induced.
(H) A model for Ed in the Hpo signaling pathway. Dashed lines indicate less characterized interactions. See text for details.
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Sav was degraded by the ubiquitin/proteasome pathway.
To determine whether Ed regulates Sav stability and subcel-
lular localization in vivo, we generated an anti-Sav antibody
(see Experimental Procedures). The specificity of this antibody
was confirmed by Sav RNAi (Figures 6E–6F0). We found that
Sav was distributed in cytoplasm with an enrichment at the
apical surface where Sav colocalized with Ed at adherens junc-
tions (Figures 6E–6G00). Ed RNAi reduced the levels of Sav immu-
nostaining at the apical region (Figures 6H–6I00 0). Consistent with
Ed regulating Sav at the posttranscriptional level, we found that
Ed RNAi also reduced the levels of HA-Sav driven by a UAS
transgene at adherens junctions (Figures S5A–S5B00). We also
found that Sav was enriched at the apical surface of ovarian
follicle cells (Figures 6J–6J00 0) and that the levels of apically local-Developmized Sav were reduced in posterior ed mutant follicle cells
(Figures 6K–6K00 0).
Because we observed that Sav physically interacts with
Ex/Mer, we also examined whether loss of Ed affects the level
or subcellular localization of Ex/Mer. We found that levels of Ex
and Mer were upregulated by Ed RNAi (Figures S5C–S5D00),
likely because of the transcriptional upregulation of ex and mer
expression in response to loss of Ed. However, loss of Ed did
not affect the apical localization of Ex/Mer (Figures S5C–S5D00).
Regulation of Ed/Sav Interaction by Ed Dimerization
and Membrane Localization
Although EdTMC interacts with Sav, the soluble Ed intracellular
domain (EdC; Figure 7A) that lacks the transmembrane domain
failed to bind Sav in our coimmunoprecipitation experimentsental Cell 22, 255–267, February 14, 2012 ª2012 Elsevier Inc. 263
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association of Ed to the membrane. To test this possibility, a
myristoylation signal was added to EdC (Myr-EdC; Figure 7A).
We found that Myr-EdC-Myc only weakly interacted HA-Sav,
suggesting that tethering Ed C-tail to the membrane is not suffi-
cient to confer efficient binding to Sav.
A previous study reported that Ed forms a dimer or oligomer
(Spencer and Cagan, 2003). Interestingly, we found that EdTMC,
but not EdC, can self-associate when expressed in S2 cells (Fig-
ure 7C), suggesting that the TM domain of Ed can mediate
dimerization/oligomerization. This observation further suggests
that Ed/Sav association may require dimerization/oligomeriza-
tion of Ed C-tail. To test this possibility, we added a coiled-coil
(CC) dimerization motif (see Experimental Procedures) to
generate Myr-CC-EdC (Figure 7A) and found that Myr-CC-EdC
could self-associate and interact effectively with Sav (Figures
7B and 7C). Adding the CC dimerization motif to the soluble
EdC (CC-EdC) did not result in strong association between CC-
EdC and Sav (data not shown), suggesting that effective interac-
tion between Ed and Sav requires both membrane localization
and dimerization of the Ed intracellular domain. Consistent with
this notion, we failed to detect an interaction between the Ed
intracellular domain and Sav in a yeast two-hybrid assay (data
not shown). Of note, membrane association of EdTMC, Myr-
EdC, and Myr-CC-EdC was confirmed by immunostaining of S2
cells transfected with these Ed variants (Figure S7).
To further characterize the Ed/Sav interaction, we carried out
fluorescence resonance energy transfer (FRET) experiments.
C-terminally CFP-tagged Ed (Ed-CFP) was transfected into S2
cells together with N- or C-terminally YFP-tagged Sav (YFP-
Sav or Sav-YFP). We observed high FRET between Ed-CFP
and YFP-Sav but low FRET between Ed-CFP and Sav-YFP (Fig-
ure 7D; Figure S6), suggesting that Ed is in close proximity with
the N-terminal region of Sav. This is consistent with the results
from immunoprecipitation experiments indicating that Ed binds
to the N-terminal region of Sav (Figures 5I and 5J). We also
observed high FRET between N-terminally CFP-tagged Sav
(CFP-Sav) and YFP-Sav but low FRET between CFP-Sav and
Sav-YFP (Figure 7D; Figure S6), suggesting that Sav forms
a parallel dimer/oligomer. Thus, association between Ed and
Sav may involve multimeric (dimer to dimer) interactions.
To determine the effect of C-tail dimerization on Ed activity
in vivo, we generated transgenic flies expressing UAS-EdC,
UAS-Myr-EdC, andUAS-Myr-CC-EdC and compared their activ-
ities by carrying out rescue experiments. We found that overex-
pression of Myr-CC-EdC, but not EdC or Myr-EdC, could
suppress the elevated ex-lacZ expression induced by Ed RNAi
(Figure S7).
Regulation of Ed/Sav Interaction by Cell-Cell Contact
A previous study showed that Ed transfected into S2 cells
could mediate cell-cell adhesion though homophilic interactions
and that Ed was enriched at cell contact sites (Islam et al.,
2003). We therefore determined whether cell-cell contact could
modulate Ed/Sav interaction. To do this, we transiently ex-
pressed low levels of EdFL-Myc and Sav-GFP using the tubulin
promoter (tub-EdFL-Myc and tub-Sav-GFP). In isolated cells,
EdFL-Myc and Sav-GFP exhibited limited colocalization (Figures
7E–7E00). Consistent with the previous finding (Bai et al., 2001),264 Developmental Cell 22, 255–267, February 14, 2012 ª2012 ElsevEdFL-Myc accumulated at the cell contact site upon cell-cell
contact (Figure 7F). Strikingly, Sav-GFP also accumulated at
the cell contact site where it colocalized with EdFL-Myc (Figures
7F0 and 7F00). Deleting the C-terminal Sav-interacting domain in
Ed (EdDC1-Myc) prevented the recruitment of Sav-GFP to the
cell contact region (Figures 7G–7G00). Thus, cell-cell contact
facilitates Ed/Sav association.
DISCUSSION
The Hpo signaling pathway has emerged as a conserved regula-
tory pathway that controls tissue growth and organ size.
Although the core pathway components—i.e., the Hpo/Sav/
Wts/Mats kinase cassette and its effector Yki/Yap—have been
well defined, the upstream regulators, especially the membrane
receptors that link cell-cell communication to Hpo signaling,
remain poorly defined. Here we provide both genetic and
biochemical evidence that the transmembrane cell adhesion
molecule Ed functions as a upstream regulator of the Hpo
pathway. We provide evidence that Ed physically interacts with
Sav/Hpo and regulates the abundance of Sav at adherens junc-
tions. Loss of Ed compromises the ability of Hpo/Wts kinase
cassette to phosphorylate Yki, leading to elevated levels of
nuclear Yki that drive tissue overgrowth. We found that Ed/Sav
association is facilitated by cell-cell contact, raising an inter-
esting possibility that Ed may serve as a mechanism that links
Hpo signaling to cell contact inhibition.
The atypical cadherin Ft functions as a receptor for the Hpo
pathway; however, Ft mainly acts through Dachs to control the
stability of Wts (Cho et al., 2006). Our genetic study indicated
that Ed does not act through Ft-Dachs to regulate Yki activity
because inactivation of Dachs did not block Yki activation
induced by loss of Ed. Furthermore, loss of Ed synergized with
loss of Ds to induce the expression of Hpo-responsive genes,
supporting a model in which Ed acts in parallel with Ds/Ft in
the Hpo pathway (Figure 7H). Several lines of evidence suggest
that Ed regulates Hpo signaling, at least in part, through Sav.
(1) Using coimmunoprecipitation, colocalization, and FRET
assays, we demonstrate that Ed physically interacts with Sav.
(2) Deleting the Sav-interacting domain in Ed compromises its
in vivo activity. (3) Ed regulates the abundance and subcellular
localization of Sav both in vitro and in vivo. (4) Overexpression
of Sav suppresses tissue overgrowth induced by loss of Ed.
Sav is a binding partner and activator of Hpo. Hence, Ed could
influence the Hpo kinase activity by regulating the abundance
and subcellular location of the Sav/Hpo complex. How Ed regu-
lates Sav stability is currently unknown; however, we found that
Sav is degraded in a proteasome-dependent manner. It is
possible that binding of Ed to Sav leads to some modifications
of Sav and prevents it from ubiquitin/proteasome-mediated
degradation.
Sav binds Ed and Hpo through its N- and C-terminal regions,
respectively (Figure 5; Jia et al., 2003; Udan et al., 2003; Wu
et al., 2003), and thus may function as a bridge to bring Hpo to
Ed. Indeed, we observed enhanced Ed/Hpo association in the
presence of cotransfected Sav. It has been suggested that
apical membrane recruitment of Hpo promotes phosphorylation
ofWts (Hergovich et al., 2005; Yu et al., 2010). Thus, it is conceiv-
able that Ed may regulate the Hpo kinase by recruiting Sav/Hpoier Inc.
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tion requires membrane association and dimerization/oligomer-
ization of Ed intracellular domain. As Sav also forms a dimer/olig-
omer (Figure 7), dimerization/oligomerization of Ed intracellular
domain may enhance binding to Sav through multimeric interac-
tions. It is also possible that membrane association and dimer-
ization/oligomerization could lead to a modification of Ed intra-
cellular domain, resulting in increased binding affinity toward
Sav.
It has been shown that the Hpo pathway can mediate cell
contact inhibition in mammalian cultured cells, although the
underlying mechanism has remained poorly defined. Interest-
ingly, we found that cell-cell contact can facilitate the recruitment
of Sav to Ed at the contact site. Cell-cell contact may facilitate
homophilic interaction in trans and clustering of Ed intracellular
domain or induce posttranslational modification of Ed C-tail at
the contact site, leading to enhanced Sav association. We
propose that regulation of Ed/Sav association may provide
a mechanism for cell-cell contact to modulate Hpo signaling
and tissue growth.
The mechanism by which Ed regulates Hpo signaling is likely
to be more complex than simply regulating Sav/Hpo. For
example, we also observed that Ed interacts with Ex/Mer/Kibra
as well as Yki. It has been proposed that enrichment of Hpo
pathway components to the apical membrane domain may facil-
itate the activation of the kinase cassette and increase the
accessibility of Yki to its kinase (Genevet and Tapon, 2011).
Our finding that Ed facilitates the apical localization of Sav lends
further support to this notion. Through interacting with multiple
components of the Hpo pathway, Ed could function as a molec-
ular scaffold to facilitate Hpo activation and Yki phosphorylation.
We found that loss of Ed did not alter the apical membrane local-
ization of Ex and Mer in wing discs even though overexpression
of Ed in S2 cells facilitates membrane recruitment of Ex. The
apical localization of Ex and Mer is likely to be mediated by other
upstream components such as Ft and Crb in the absence of Ed.
Indeed, Crb physically interacts with Ex, and both loss and gain
of function of Crb causedmislocalization of a fraction of Ex to the
basal region (Chen et al., 2010; Grzeschik et al., 2010; Robinson
et al., 2010). It has been shown that Ex physically interacts with
Yki, which may sequester Yki in the cytoplasm independent of
Yki phosphorylation (Badouel et al., 2009). Our finding that Ed
interacts with Yki through a domain distinct from thosemediating
its binding to the upstream Hpo pathway components raises
a possibility that Ed may also directly sequester Yki in the cyto-
plasm in addition to regulating its subcellular localization through
phosphorylation.
It is interesting to note that Ed is related to TSLC1, a tumor
suppressor implicated in human non-small-cell lung cancer and
other cancers including liver, pancreatic, and prostate cancers
(Kuramochi et al., 2001; Murakami, 2005). Like Ed, TSLC1 also
mediates cell-cell adhesion through homophilic interactions
(Masuda et al., 2002). TSLC1 interacts with MPP3, a human
homolog of Drosophila tumor suppressor Discs large (Dlg) that
has been implicated in the Hpo pathway (Fukuhara et al., 2003;
Grzeschik et al., 2010), as well as DAL-1, a FERM-domain con-
taining tumor suppressor related to Ex/Mer (Yageta et al.,
2002). Therefore, it would be interesting to determine whether
TSLC1 inhibits tumor formation through the Hpo pathway.DevelopmEXPERIMENTAL PROCEDURES
Mutants and Transgenes
ed1X5 is a strong allele (Bai et al., 2001). To generate ed mutant or control
clones in adult eyes, y w ey-FLP; l(2)cl-L3 P[w+] FRT40/Cyo (BL#5622) flies
were crossedwith ed1X5 FRT40 /Cyo or FRT40 flies. Marked ed clones in imag-
inal discs were generated using the Minute technique with the following geno-
type: hs-FLP; FRT40 M (2)24F arm-lacZ/ FRT40 ed1X5. FLP/FRT-mediated
mitotic recombination was induced 1–2 days after egg laying by incubating
the larvae at 37C for 1 hr. The genotypes for generating clones in ovaries
are as follows: ed clones: y w hs-flp; FRT40 ed1X5 FRT40 / arm-LacZ; ed clones
expressing various transgenes: y w hs-flp; FRT40 ed1X5/FRT40 tub-Gal80;
UAS-transgenes/tub-Gal4 UAS-GFP. Transgenic RNAi lines used are:
UAS-Ed-RNAi937 (VDRC# 937), UAS-Ed-RNAi3087 (VDRC# 3087), UAS-
Ed-RNAi104279 (VDRC# 104279), UAS-Ft-RNAi (VDRC# 9396), UAS-Ds-RNAi
(VDRC # 36219), UAS-Dachs-RNAi (VDRC# 12556), UAS-EGFR-RNAi
(VDRC# 43267), UAS-Yki-RNAi (Zhang et al., 2008), UAS-Sav-RNAi (BL#
28006), and UAS-Ed-RNAiC targeting the C-terminal region of Ed between
aa1216 and aa1332. Other transgenes used in this study include bantam
sensor (Brennecke et al., 2003), ex-lacZ (Hamaratoglu et al., 2006), diap1-
GFP (Zhang et al., 2008), UAS-Ed (Fetting et al., 2009), and UAS-HA-Sav
(Jia et al., 2003). To generateUAS-Myr-EdC andUAS-Myr-CC-EdC constructs,
DNA fragments corresponding to a myristoylation signal, GNKCCSKRQ,
and the leucine zipper CC dimerization domain of the yeast GCN4 (O’Shea
et al., 1991; Zhang et al., 2009b) are synthesized and inserted into the
N-terminus of EdC. Transgenic flies carrying UAS-EdFL-Myc, UAS-EdTMC-
Myc, UAS -EdTMCD1-Myc, UAS EdTMCD2-Myc, UAS-EdC, UAS-Myr-EdC and
UAS-Myr-CC-EdC were generated by P-element transformation.
Cell Culture, Transfection, Immunoprecipitation, and Western
Blot Analysis
Drosophila S2 cells were cultured in Drosophila Schneider’s medium (Invitro-
gen) with 10% fetal bovine serum, 100 U/ml penicillin, and 100mg/ml strepto-
mycin. Transfection was carried out with the Calcium Phosphate Transfection
Kit (Specialty Media) according to manufacturer’s instructions. The construct
of ubiquitin-Gal4 was cotransfected with pUAST expression vectors for all the
transfection experiments except for the cell-cell contact-induced Ed/Sav inter-
action experiment, in which tub-EdFL-Myc, tub-EdDC1-Myc, and tub-Sav-GFP
were used. We conducted immunoprecipitation and western blot analyses
using standard protocols as previously described. MG132 (Calbiochem) was
used at 50 mM. Transfected S2 cells were treated with Cycloheximide (Sigma)
at a final concentration of 100 mM for the indicated time periods before harvest-
ing. For endogenous protein detection, wing imaginal discs were collected
from the late third instar larvae and lysed in NP40 cell lysis buffer with protease
inhibitor cocktail (Roche). Lysates were cleared by centrifugation and
subjected to SDS-PAGE. Western blot was performed with rabbit anti-Yki
(1:1000, K. Irvine), rabbit anti-phospho-Yki (1:1000, D. Pan), mouse anti-
a-Tubulin (1:100,000, Sigma), rat anti-Ed (1:1000, J. Hsu), and rabbit anti-
Sav (1:1000).
Immunohistochemistry
To generate Sav antibodies, we cloned full-length Sav cDNA into pET30. His-
Sav was expressed in BL21 E.coli (Invitrogen) by induction with 0.1 mM IPTG.
Sav protein was purified on SDS-PAGE and used to immunize rabbits
(Cocalico Biologicals). Other antibodies used were mouse anti-b-Gal
(1:1000, Promega), rabbit anti-b-Gal (1:1000, Affinity Bioreagents), mouse
anti-Wg (1:100, DSHB), rat anti-Ci, 2A1 (Motzny and Holmgren, 1995), rabbit
anti-Yki (1:1000, K. Irvine), rabbit anti-GFP (Molecular Probes), guinea pig
anti-Ex (1:5000) and guinea pig anti-Mer (1:5000, R. Fehon), rat anti-Ed
(1:1000, J. Hsu), rat anti-E-cad (1:100, DHSB), rabbit anti-Sav (1:100),
DRAQ5 (cell signaling), mouse anti-Grk (DSHB), mouse anti-HA, mouse anti-
Myc, and mouse anti-Fg (Santa Cruz). Cy2-, Cy3- and Cy5-conjugated
secondary antibodies were from Jackson ImmunoResearch Laboratories.
Images were captured by Zeiss LSM510 confocal microscopy.
FRET Analysis
FRET analysis was carried out as previously described (Zhao et al., 2010).
CFP/YFP-tagged constructs were transfected into S2 cells together with anental Cell 22, 255–267, February 14, 2012 ª2012 Elsevier Inc. 265
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formaldehyde for 20 min, and mounted on slides in 80% glycerol. CFP signals
were acquired with 1003 objective of Zeiss LSM510 confocal microscope
before photobleaching YFP (BP) and after photobleaching YFP (AP). Each
data set was calculated with 10–20 individual cells. In each cell, four or five
regions of interest in the photobleached area were selected for analysis. The
intensities of CFP signals were quantified by ImageJ software. We calculated
the FRET efficiency using the formula: FRET% = [(CFPAP  CFPBP)/CFPAP] 3
100. Of note, only CFP signals that colocalized with YFP signals (both
membrane and intracellular) were selected for calculation.
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